跳至主要内容
临床试验/CTRI/2026/01/102118
CTRI/2026/01/102118尚未招募2 期

Efficacy 0f fasd venesection and tila in dawali primary varicose vein a randomised controlled clinical trail

Dr misba usmani1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2026年2月7日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
48
试验地点
1

研究概览

简要总结

Diagnosed cases of primary varicose vein fulfilling the inclusion criteria will be randomly selected after obtaining written informed consent. Participants will be randomly allocated into two groups, with 24 patients in each group. The test group will be treated with fasd and local application of tila daily for 14 days, while the control group will be treated with compression stockings for 14 days. Patients will be assessed for primary and secondary outcome measures at baseline and after completion of the treatment period. The significance of differences between the two groups will be analyzed using appropriate statistical tests.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Outcome Assessor Blinded

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients clinically diagnosed with primary varicose veins Varicosity Mild to Moderate on venous clinical severity score Patients between 30 to 60 years of Age Either gender Willing to sign the informed consent form.

排除标准

  • Patients having grade II hypertension Pregnant and lactating women Patients who fail to follow up Patients having uncontrolled Diabetes mellitus and other Systemic illness Patients with Hb less than 9.5 Patients having bleeding diathesis, HIV infection, hepatitis B and C infection Patients of deep venous thrombosis Patients having varicose ulcers.

研究者

发起方
Dr misba usmani
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Misba Usmani

National institute of unani medicine

研究点 (1)

Loading locations...

相似试验

effect of regimenal therapy in primary varicose vein | 临床试验